» Articles » PMID: 34697449

HOTAIR/Sp1/miR-199a Critically Regulates Cancer Stemness and Malignant Progression of Cutaneous Squamous Cell Carcinoma

Overview
Journal Oncogene
Date 2021 Oct 26
PMID 34697449
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The long non-coding RNA (lncRNA), HOX antisense intergenic RNA (HOTAIR) is a well-characterized oncogene in multiple human cancers, but not in cutaneous squamous cell carcinoma (CSCC). In this study, we focused on investigating the potential role of HOTAIR in stemness of CSCC. By measuring its expression using RT-qPCR in CSCC vs. normal tissues, as well as in CSCC cell lines A431 or SCC13, A431- or SCC13-derived CSCC stem cells (CSCSCs), and normal skin fibroblasts (HSFs), we detected higher expression of HOTAIR in CSCC than in normal tissues, in recurrent than in non-recurrent CSCC tissues, in CSCCs and CSCSCs than in HSFs, and particularly, in CSCSCs than in CSCCs. Kaplan-Meier analysis suggested that higher expression of HOTAIR was positively correlated with worse overall survival of CSCC patients. Functional assays on colony formation, EdU incorporation, sphere formation, western blot on stem-cell biomarkers, and in vivo models showed that HOTAIR was essential in maintaining multiple stem cell phenotypes of CSCSCs in vitro and in vivo xenograft growth as well as metastasis. Mechanistically, HOTAIR directly interacted with and up-regulated Sp1. Sp1 then induced DNMT1-mediated promoter methylation and direct transcriptional repression of miR-199a-5p. Targeting Sp1 or DNMT1 further boosted the in vivo anti-tumor and anti-metastasis activities of targeting HOTAIR. In conclusion, HOTAIR, by up-regulating Sp1 and targeting miR-199a, promotes stemness and progression of CSCC. Targeting HOTAIR, Sp1 or the underlying mechanisms may thus benefit CSCC treatment.

Citing Articles

HOTAIR in cancer: diagnostic, prognostic, and therapeutic perspectives.

Nazari M, Babakhanzadeh E, Mollazadeh A, Ahmadzade M, Mohammadi Soleimani E, Hajimaqsoudi E Cancer Cell Int. 2024; 24(1):415.

PMID: 39702144 PMC: 11660992. DOI: 10.1186/s12935-024-03612-x.


Circular RNA NINL accelerates the malignant progression of cervical cancer.

Cao C, Zhang H, Zhang T, Nie C Discov Oncol. 2024; 15(1):766.

PMID: 39692846 PMC: 11655911. DOI: 10.1007/s12672-024-01588-8.


Long noncoding RNA MALAT1 in dermatologic disorders: a comprehensive review.

Ruiz-Ojeda D, Guzman-Martin C, Bojalil R, Balderas X, Paredes-Gonzalez I, Gonzalez-Ramirez J Biomark Med. 2024; 18(19):853-867.

PMID: 38982732 PMC: 11497971. DOI: 10.1080/17520363.2024.2369044.


A concise review of the regulatory, diagnostic, and prognostic implications of HOXB-AS3 in tumors.

Wu H, Ye J, Zhang M, Luo H J Cancer. 2024; 15(3):714-728.

PMID: 38213732 PMC: 10777036. DOI: 10.7150/jca.91033.


Crosstalk between Noncoding RNAs and the Epigenetics Machinery in Pediatric Tumors and Their Microenvironment.

Pathania A Cancers (Basel). 2023; 15(10).

PMID: 37345170 PMC: 10216492. DOI: 10.3390/cancers15102833.


References
1.
Burton K, Ashack K, Khachemoune A . Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease. Am J Clin Dermatol. 2016; 17(5):491-508. DOI: 10.1007/s40257-016-0207-3. View

2.
Wang Y, Sun B, Wen X, Hao D, Du D, He G . The Roles of lncRNA in Cutaneous Squamous Cell Carcinoma. Front Oncol. 2020; 10:158. PMC: 7059100. DOI: 10.3389/fonc.2020.00158. View

3.
Koh S, Brasch H, De Jongh J, Itinteang T, Tan S . Cancer stem cell subpopulations in moderately differentiated head and neck cutaneous squamous cell carcinoma. Heliyon. 2019; 5(8):e02257. PMC: 6709152. DOI: 10.1016/j.heliyon.2019.e02257. View

4.
Kokko L, Hurme S, Maula S, Alanen K, Grenman R, Kinnunen I . Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma. Oral Oncol. 2011; 47(6):510-6. DOI: 10.1016/j.oraloncology.2011.03.026. View

5.
Olivero C, Morgan H, Patel G . Identification of Human Cutaneous Squamous Cell Carcinoma Cancer Stem Cells. Methods Mol Biol. 2018; 1879:415-433. DOI: 10.1007/7651_2018_134. View